These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11096145)

  • 1. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
    Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
    Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrate treatment can increase serum creatinine levels.
    Tsimihodimos V; Kakafika A; Elisaf M
    Nephrol Dial Transplant; 2001 Jun; 16(6):1301. PubMed ID: 11390746
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J; Bargman JM
    Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661
    [No Abstract]   [Full Text] [Related]  

  • 4. Creatinine rise after fibrate therapy in renal graft recipients.
    Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C
    Lancet; 1993 Mar; 341(8848):840. PubMed ID: 8096050
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.
    Maiguma T; Fujisaki K; Itoh Y; Makino K; Teshima D; Takahashi-Yanaga F; Sasaguri T; Oishi R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):289-96. PubMed ID: 12644902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrates and renal function.
    Gajdos M; Dzúrik R
    Clin Nephrol; 2003 Jul; 60(1):65-6. PubMed ID: 12872864
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterioration in renal function associated with fibrate therapy.
    Lipscombe J; Lewis GF; Cattran D; Bargman JM
    Clin Nephrol; 2001 Jan; 55(1):39-44. PubMed ID: 11200866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins.
    Zimetbaum P; Frishman WH; Kahn S
    J Clin Pharmacol; 1991 Jan; 31(1):25-37. PubMed ID: 2045526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L; Szostak WB
    Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M; Salko T; Isaacsohn JL; Troendle AJ; Dejager S; Gonasun L
    Am J Cardiol; 2003 Oct; 92(7):794-7. PubMed ID: 14516878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrate-induced deterioration of renal function].
    Polanco N; Hernández E; González E; Gutiérrez Martínez E; Bello I; Gutiérrez-Millet V; García F; Morales E; Praga M
    Nefrologia; 2009; 29(3):208-13. PubMed ID: 19554053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrate-induced increase in serum urea and creatinine levels.
    Tsimihodimos V; Bairaktari E; Elisaf M
    Nephrol Dial Transplant; 2002 Apr; 17(4):682; author reply 682. PubMed ID: 11917069
    [No Abstract]   [Full Text] [Related]  

  • 14. Fenofibrate: altered renal function.
    Prescrire Int; 2011 Jun; 20(117):154-5. PubMed ID: 21682015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORONARY EFFECT OF FIBRATES ON PROTEINS AND ENZYMES WHICH HYDROLYZE TRIACYLGLYCEROLS.
    Francik R; Kryczyk J; Francik S
    Acta Pol Pharm; 2016; 73(3):579-88. PubMed ID: 27476274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.
    Wu J; Song Y; Li H; Chen J
    Eur J Clin Pharmacol; 2009 Dec; 65(12):1169-74. PubMed ID: 19756555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
    Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
    Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofibrate versus gemfibrozil in the treatment of primary hyperlipidaemia.
    Knipscheer HC; de Valois JC; van den Ende B; Wouter ten Cate J; Kastelein JJ
    Atherosclerosis; 1996 Jul; 124 Suppl():S75-81. PubMed ID: 8831919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Westphal S; Dierkes J; Luley C
    Lancet; 2001 Jul; 358(9275):39-40. PubMed ID: 11454380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database].
    Humbert X; Dolladille C; Sassier M; Valnet-Rabier MB; Vial T; Guitton E; Page A; Sole E; Auriche P; Coquerel A; Alexandre J; Fedrizzi S
    Therapie; 2017 Dec; 72(6):677-682. PubMed ID: 28941579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.